Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP907518.RA44BTJnqaL3V34WuFx2YmAkQv0mp5VyMhC4PsOsta4iU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP907518.RA44BTJnqaL3V34WuFx2YmAkQv0mp5VyMhC4PsOsta4iU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP907518.RA44BTJnqaL3V34WuFx2YmAkQv0mp5VyMhC4PsOsta4iU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP907518.RA44BTJnqaL3V34WuFx2YmAkQv0mp5VyMhC4PsOsta4iU130_provenance.
- NP907518.RA44BTJnqaL3V34WuFx2YmAkQv0mp5VyMhC4PsOsta4iU130_assertion description "[MET, a receptor tyrosine kinase for hepatocyte growth factor, is associated with tumor progression and acquired resistance to epidermal growth factor tyrosine kinase inhibitors (EGFR-TKI).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP907518.RA44BTJnqaL3V34WuFx2YmAkQv0mp5VyMhC4PsOsta4iU130_provenance.
- NP907518.RA44BTJnqaL3V34WuFx2YmAkQv0mp5VyMhC4PsOsta4iU130_assertion evidence source_evidence_literature NP907518.RA44BTJnqaL3V34WuFx2YmAkQv0mp5VyMhC4PsOsta4iU130_provenance.
- NP907518.RA44BTJnqaL3V34WuFx2YmAkQv0mp5VyMhC4PsOsta4iU130_assertion SIO_000772 21733594 NP907518.RA44BTJnqaL3V34WuFx2YmAkQv0mp5VyMhC4PsOsta4iU130_provenance.
- NP907518.RA44BTJnqaL3V34WuFx2YmAkQv0mp5VyMhC4PsOsta4iU130_assertion wasDerivedFrom befree-2016 NP907518.RA44BTJnqaL3V34WuFx2YmAkQv0mp5VyMhC4PsOsta4iU130_provenance.
- NP907518.RA44BTJnqaL3V34WuFx2YmAkQv0mp5VyMhC4PsOsta4iU130_assertion wasGeneratedBy ECO_0000203 NP907518.RA44BTJnqaL3V34WuFx2YmAkQv0mp5VyMhC4PsOsta4iU130_provenance.
- befree-2016 importedOn "2016-02-19" NP907518.RA44BTJnqaL3V34WuFx2YmAkQv0mp5VyMhC4PsOsta4iU130_provenance.